Envestnet Asset Management Inc. raised its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Free Report) by 18.6% in the fourth quarter, according to its most recent filing with the SEC. The firm owned 453,801 shares of the medical instruments supplier's stock after purchasing an additional 71,213 shares during the quarter. Envestnet Asset Management Inc. owned approximately 0.23% of DENTSPLY SIRONA worth $8,613,000 at the end of the most recent quarter.
Other large investors also recently modified their holdings of the company. Riverview Trust Co acquired a new stake in shares of DENTSPLY SIRONA during the 4th quarter worth approximately $26,000. MassMutual Private Wealth & Trust FSB lifted its stake in shares of DENTSPLY SIRONA by 648.4% in the fourth quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier's stock valued at $27,000 after buying an additional 1,232 shares in the last quarter. UMB Bank n.a. lifted its position in shares of DENTSPLY SIRONA by 60.8% during the fourth quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier's stock valued at $28,000 after purchasing an additional 564 shares in the last quarter. Mitsubishi UFJ Asset Management Co. Ltd. lifted its position in shares of DENTSPLY SIRONA by 700.0% during the fourth quarter. Mitsubishi UFJ Asset Management Co. Ltd. now owns 1,792 shares of the medical instruments supplier's stock valued at $33,000 after purchasing an additional 1,568 shares in the last quarter. Finally, Signaturefd LLC lifted its position in shares of DENTSPLY SIRONA by 513.3% during the fourth quarter. Signaturefd LLC now owns 4,428 shares of the medical instruments supplier's stock valued at $84,000 after purchasing an additional 3,706 shares in the last quarter. Institutional investors and hedge funds own 95.70% of the company's stock.
Insider Activity
In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the firm's stock in a transaction dated Monday, March 3rd. The stock was acquired at an average cost of $16.51 per share, for a total transaction of $249,994.42. Following the completion of the transaction, the director now owns 81,971 shares in the company, valued at $1,353,341.21. This trade represents a 22.66 % increase in their ownership of the stock. The acquisition was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website. Insiders own 0.52% of the company's stock.
Analyst Upgrades and Downgrades
A number of research analysts recently weighed in on XRAY shares. Needham & Company LLC reissued a "hold" rating on shares of DENTSPLY SIRONA in a research report on Thursday, March 13th. Barrington Research decreased their target price on shares of DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating on the stock in a research report on Friday, February 28th. Robert W. Baird decreased their price objective on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Mizuho decreased their price objective on shares of DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating on the stock in a research report on Thursday, March 13th. Finally, Jefferies Financial Group lowered shares of DENTSPLY SIRONA from a "buy" rating to a "hold" rating and cut their target price for the company from $30.00 to $20.00 in a research note on Thursday, January 23rd. Thirteen analysts have rated the stock with a hold rating and two have assigned a buy rating to the company's stock. According to MarketBeat, DENTSPLY SIRONA currently has an average rating of "Hold" and an average target price of $22.58.
Check Out Our Latest Analysis on XRAY
DENTSPLY SIRONA Price Performance
Shares of DENTSPLY SIRONA stock traded up $0.28 during trading hours on Thursday, hitting $13.56. The company's stock had a trading volume of 310,385 shares, compared to its average volume of 2,949,117. DENTSPLY SIRONA Inc. has a 12-month low of $12.16 and a 12-month high of $31.00. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The business has a 50 day moving average price of $15.28 and a two-hundred day moving average price of $18.48. The company has a market cap of $2.70 billion, a PE ratio of -6.54, a PEG ratio of 1.80 and a beta of 0.92.
DENTSPLY SIRONA Dividend Announcement
The business also recently disclosed a quarterly dividend, which was paid on Friday, April 11th. Shareholders of record on Friday, March 28th were paid a dividend of $0.16 per share. The ex-dividend date was Friday, March 28th. This represents a $0.64 annualized dividend and a yield of 4.72%. DENTSPLY SIRONA's payout ratio is currently -14.07%.
DENTSPLY SIRONA Profile
(
Free Report)
DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.
Featured Stories

Before you consider DENTSPLY SIRONA, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DENTSPLY SIRONA wasn't on the list.
While DENTSPLY SIRONA currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for May 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.